Ana Xu

Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy

Ying Qu, Feifei Sun, Feng He et al. · European Journal of Pharmaceutical Sciences · 2019 · 51 citations

Nanomedicine, Drug Targeting, Polymer-drug Conjugate +8

Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: Design, synthesis, and biological evaluation

Ana Xu, Feng He, Xiangna Zhang et al. · Bioorganic Chemistry · 2020 · 34 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +10

Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease

Feng He, Yingying Ran, Xiaoyang Li et al. · Bioorganic Chemistry · 2020 · 27 citations

Neurodegenerative Diseases, Alzheimer's Disease, Dual-function Inhibitors +10

Highly enantioselective synthesis of both tetrahydroquinoxalines and dihydroquinoxalinones<i>via</i>Rh–thiourea catalyzed asymmetric hydrogenation

Ana Xu, Chaoyi Li, Junrong Huang et al. · Chemical Science · 2023 · 16 citations · Full text

Design, synthesis and activity evaluation of indole-based double – Branched HDAC1 inhibitors

Qiuqiong Zhang, Jiahui Lv, Feng He et al. · Bioorganic & Medicinal Chemistry · 2019 · 14 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +11